ResMed (RMD) came out with quarterly earnings of $2.81 per share, beating the Zacks Consensus Estimate of $2.69 per share. This compares to earnings of $2.43 per share a year ago. These figures are ...
WASHINGTON, Jan. 27, 2026 /PRNewswire/ -- The Horatio Alger Association of Distinguished Americans, Inc., a nonprofit that honors leaders who have overcome adversity and supports young people in ...
ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, ...
RMD is trading in the middle of its 52-week range and below its 200-day simple moving average. Price change The price of RMD shares has decreased $12.63 since the market last closed. This is a 4.87% ...
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
WASHINGTON – Resmed CEO Mick Farrell has become the first leader from the home care sector to chair the board of directors at AdvaMed, the trade association representing major medtech companies. His ...
ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, ...
Nasdaq Dividend History provides straightforward stock’s historical dividends data. Dividend payout record can be used to gauge the company's long-term performance when analyzing individual stocks.
The long-term growth opportunity for respiratory homecare devices is sizable as both developed and emerging markets are still significantly underpenetrated.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results